NewsRoom Articles

WednesdayAug 05, 2026 10:00 am

Existing Immune Protein May Boost Immunotherapy Against Cancer

Nagoya University researchers have discovered an ancient protein that occurs naturally in a wide variety of animals and has the potential to make immunotherapy treatments more effective. C3, a protein produced in the liver, typically helps the body fight off infections. However, when the protein is produced by cells within a tumor, it seems to act against immunosuppressive cells, making tumors more susceptible to immunotherapy. The researchers believe inducing C3 creation in tumors with low C3 levels could make immunotherapy more effective at eradicating cancerous cells from the body. Lead study author Yuki Miyai, an assistant professor at Nagoya University’s…

TuesdayAug 04, 2026 9:00 am

Azio AI Holdings Inc. (NASDAQ: AZIO) Is ‘One to Watch’

AZIO AI is building an integrated technology infrastructure platform focused on AI data centers, enterprise GPU compute, high-performance computing and digital power solutions. In July 2026, the company completed its merger with AZIO AI Corporation and subsequently changed its corporate name and Nasdaq ticker symbol from EVTV to AZIO, completing its transformation into a dedicated AI infrastructure company. AZIO AI has announced a $27.9 million AI infrastructure and capacity agreement with Power Champion Investment Limited that is scalable to as much as $100 million as deployment expands. The company has reported receiving initial deposits under the agreement. The company recently…

MondayAug 03, 2026 10:00 am

Coal Imports into Asia Continue Their Rebound

Thermal coal imports into Asia have surged for the third consecutive month, backed by summer demand from Japan, South Korea, and other major players. Despite the region’s notable commitment to renewables, Asia currently consumes nearly 90% of global seaborne thermal coal. China undoubtedly leads the pack thanks to its energy-intensive manufacturing hubs, with experts predicting the country’s thermal coal imports will reach 28.14 million tons this month, up from 24.1 million last July. Commodity analyst Kpler predicts Asia’s seaborne thermal coal imports will hit 73.16 million metric tons in July, jumping nearly 3 million tons from last month. Coal mostly serves as a source of electricity for many Asian nations…

WednesdayJul 29, 2026 10:00 am

Tech Firms and Lawmakers Are Increasingly Worried About AI Distillation

As Chinese artificial intelligence (AI) continues to pressure leading Western models, lawmakers and industry leaders are becoming increasingly worried about AI distillation. The concept gained mainstream attention in early 2026 when Jeff Dean, the AI lead at Google, appeared on a podcast where he discussed the company’s efforts to improve its models. He noted that distillation is a method AI firms can use to boost the capabilities of their smaller models, typically by distilling a broader model down into a smaller one. Months later, AI distillation has become a trending topic across Washington, D.C., and Silicon Valley amidst advances in Chinese AI. Moonshot AI, a Beijing-based lab formed in 2023,…

MondayJul 27, 2026 10:00 am

Experimental Immunotherapy Offers Hope Against Deadly Pediatric Brain Cancer

Research published in the journal Nature Medicine has revealed that experimental immunotherapy may provide some relief to patients with aggressive pediatric cancers. Spinal cord and brain tumors tend to have the most detrimental effects on pediatric patients, but current treatment protocols often have low success rates. The experimental treatment from researchers at Children’s National Hospital could open the door to more effective cancer treatments for children afflicted with deadly brain cancers. Dubbed tumor-associated antigen (TAA) T cell therapy, this experimental treatment has already gone through early-stage clinical trials with encouraging results. Several pediatric cancer patients who went through the therapy have been declared cancer-free and have remained so years after…

WednesdayJul 22, 2026 10:00 am

Dietary Fat Balance Could Influence Immune System Function, Study Finds

A new study suggests that theratio of two common dietary fats may profoundly influence how well your immune system fights infection and cancer. Specifically, the balance between polyunsaturated and monounsaturated fats could alter the composition of immune cell membranes, making the cells more vulnerable to a destructive process called ferroptosis. Polyunsaturated fats, found abundantly in foods like salmon, walnuts, and vegetable oils, contain chemical bonds that are prone to breaking down through a process called oxidation. Monounsaturated fats, found in olive oil, avocados, and nuts, have fewer vulnerable bonds and remain more stable under oxidative stress. The difference is purely…

MondayJul 20, 2026 10:00 am

Trump’s Energy Policies Cause Delay, Cancellation of Renewables Projects Worth $83B

The current administration’s approach to clean energy policy has led to the cancellation of $83 billion worth of renewables projects. Unlike the Biden administration, which prioritized and invested in sustainability, the Trump administration has taken the complete opposite stance. From the moment President Trump assumed office for his second term, his administration has reversed dozens of green energy policies and wreaked havoc on America’s fledgling renewables industry. With the administration cutting policy support for the industry, a BlueGreen Alliance report notes that hundreds of renewable energy projects across the country are now cancelled. The labor and environmental coalition published the report just as American labor leaders get ready to…

WednesdayJul 15, 2026 10:00 am

Backlash Prompts Meta to Take Down its AI Image Generation Feature

Meta has removed its newly launched Muse Image tool after facing widespread backlash over privacy concerns and automatic enrollment of public account users. The feature enrolled all public-facing profile users by default unless they manually disabled it in settings. Creators, privacy advocates, and industry representatives quickly objected to the default opt-out structure, arguing that it violated established user consent principles and likeness rights protections. Within days of release, Meta removed the feature entirely, acknowledging in a statement that it had "missed the mark" on implementation and user expectations. Meta's Muse Image represented the company's initial entry into AI-generated imagery, accessible through the Meta AI chatbot interface. The tool synthesized…

MondayJul 13, 2026 10:00 am

Widely Prescribed Thyroid Hormone Could Prevent Pediatric Brain Tumor Recurrence

A research team investigating children's brain tumors has found promising results combining a hormone treatment with standard chemotherapy protocols. Triiodothyronine, commonly called T3, is a medication long used to manage thyroid disorders in patients throughout the lifespan. The hormone showed enhanced effectiveness when added to conventional cancer therapy in laboratory studies and animal models. A clinical trial is now recruiting pediatric patients to test whether this combined approach works in actual clinical settings. Medulloblastoma accounts for the leading category of malignant pediatric brain cancers, striking hundreds of young children annually. Treatment currently requires aggressive intervention that combines surgical removal with systemic therapy and radiation.…

WednesdayJul 08, 2026 10:00 am

AI Tool Predicts the Optimal Presurgical Treatments for Breast Cancer

A new AI tool developed at Cedars-Sinai could change how doctors pick the most suitable presurgical therapy for breast cancer patients. The tool, called BRIDGE, was detailed in Annals of Oncology alongside early validation data. It reads genetic signals inside a tumor to identify which subtypes are present, rather than forcing the whole mass into one category. Treatment decisions for patients with breast cancer depend on how each tumor is classified and labeled. Doctors sort masses into groups like triple-negative or HER2-positive, then select from chemotherapy, targeted therapy, or immunotherapy given before the operation. When that approach works, a patient…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000